Tackling cell therapy’s biggest challenges: Why new pathways are needed in biomanufacturing and patient access
By Biobridge
Download this whitepaper for a detailed examination of patient access challenges and solutions in cell therapies. Momentum is growing in the cell therapy field, but a complex web of barriers is currently limiting patients’ abilities to access these lifechanging treatments both in clinical trial and commercial settings. This whitepaper explores emerging solutions to the industry’s biggest challenges, from decentralised infrastructure for leukapheresis to point-of-care manufacturing for reduced vein-to-vein times.